Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Biotech
Moderna plants new cancer vaccine trials, weeds PD-L1 work
Moderna ended development of a preclinical PD-L1-targeting therapy while deepening work on a Merck-partnered neoantigen med.
Max Bayer
May 2, 2024 11:00am
Regeneron, Lilly grapple with clinical endpoints in obesity
May 2, 2024 10:38am
Pfizer plans to be 'very active' in obesity despite setbacks
May 1, 2024 1:42pm
GE HealthCare's Q1 falls flat after China sales slide
Apr 30, 2024 11:43am
Labcorp picks up Invitae portfolio for $239M in bankruptcy sale
Apr 26, 2024 11:01am
Boston Scientific sees 70% EP growth after Farapulse launch
Apr 25, 2024 10:00am